Experience of treatment of prosthetic valve endocarditis
a retrospective single-center cross-sectional study
Keywords:
Endocarditis, Heart valve prosthesis, Cardiac surgical proceduresAbstract
BACKGROUND: The aim of this study was to describe the experience of treatment of early prosthetic valve endocarditis at a heart center. DESIGN AND SETTING: Retrospective single-center study on data collected from electronic medical records covering the period from January 2009 to December 2015. METHODS: Over the study period, 1,557 consecutive valve operations were performed on adult patients. The study population comprised 32 patients (2%) who were diagnosed with prosthetic valve endocarditis within 12 months after the index surgery. Medical records were retrieved from electronic hospital records, retrospectively. Descriptive clinical, echocardiographic, microbiological and treatment-type data were used. Risk factors for early mortality were studied through univariate and multivariate analyses. RESULTS: The main clinical manifestation of infective endocarditis was fever, and this was present in all patients. Most of the prostheses were affected in the aortic position (40.6% of cases). The most commonly cultured microorganisms were Staphylococcus epidermidis and Staphylococcus aureus. Twenty-six patients (81.3%) underwent surgical treatment and six (18.7%) underwent exclusive clinical treatment. The prevalence of postoperative complications was 31.3% and hospital mortality occurred in seven cases (21.9%). The mortality rate was 50% among the patients who underwent medical treatment and 15.4% among those who underwent surgery. There were no independent risk factors for mortality. CONCLUSION: Prosthetic valve endocarditis is an infrequent complication of valve replacement. Surgical treatment has mortality rates compatible with the severity of patients’ conditions. Surgical indication should not be delayed when clinical treatment has been ineffective.
Downloads
References
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1-52. PMID: 26373316; doi: 10.1161/CIR.0000000000000296.
Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). Circulation. 2006;114:e84-e231. doi: 10.1161/CIRCULATIONAHA.106.176857. Available from: Available from: http://circ.ahajournals.org/content/114/5/e84 Accessed in 2018 (21 May).
Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379(9819):965-75. PMID: 22317840; doi: 10.1016/S0140-6736(11)60755-1.
Bedeir K, Reardon M, Ramlawi B. Infective endocarditis: perioperative management and surgical principles. J Thorac Cardiovasc Surg. 2014;147(4):1133-41. PMID: 24412256; doi: 10.1016/j.jtcvs.2013.11.022.
Prendergarst BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121(9):1141-52. PMID: 20212293; doi: 10.1161/CIRCULATIONAHA.108.773598.
Delahaye F. Is early surgery beneficial in infective endocarditis? A systematic review. Arch Cardiovasc Dis. 2011;104(1):35-44. PMID: 21276576; doi: 10.1016/j.acvd.2010.11.003.
Wang A, Pappas P, Anstrom KJ, et al. The use and effect of surgical therapy for prosthetic valve infective endocarditis: a propensity analysis of a multicenter, international cohort. Am Heart J. 2005;150(5):1086-91. PMID: 16291003; doi: 10.1016/j.ahj.2005.01.023.
David TE, Gavra G, Feindel CM, et al. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg. 2007;133(1):144-9. PMID: 17198801; doi: 10.1016/j.jtcvs.2006.08.060.
Pérez-Vázquez A, Fariñas MC, García-Palomo JD, et al. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: could sensitivity be improved? Arch Intern Med. 2000;160(8):1185-91. PMID: 10789613.
Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354-61. PMID: 17392239; doi: 10.1001/jama.297.12.1354.
Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? A multicenter study of 104 cases. Heart. 2005;91(7):954-9. PMID: 15958370; doi: 10.1136/hrt.2004.046177.
Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173(16):1495-504. PMID: 23857547; doi: 10.1001/jamainternmed.2013.8203.
Pomerantzeff PMA, Pêgo-Fernandes PM, Kioka K, et al. Tratamento cirúrgico da endocardite em prótese valvular cardíaca [Surgical treatment of endocarditis in prosthetic valves]. Rev Bras Cir Cardiovasc. 1989;4(1):43-50. doi: 10.1590/S0102-76381989000100005.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-8. PMID: 10770721; doi: 10.1086/313753.
Ruiz Jr E, Schirmbeck T, Figueiredo LTM. Study about infective endocarditis in Ribeirão Preto, SP - Analysis of cases from 1992 to 1997. Arq Bras Cardiol. 2000;74(3):225-31. doi: 10.1590/S0066-782X2000000300004.
Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11(2):202-19. PMID: 20223755; doi: 10.1093/ejechocard/jeq004.
Ribeiro DGL, Silva RP, Sobrinho CR, et al. Infective valve endocarditis treated by surgery: analysis of 64 cases. Braz J Cardiovasc Surg. 2005;20(1):75-80. doi: 10.1590/S0102-76382005000100016.
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-93. PMID: 26341945; doi: 10.1016/S0140-6736(15)00067-7.
Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of culture-negative endocarditis. Medicine (Baltimore). 2003;82(4):263-73. PMID: 12861104; doi: 10.1097/01.md.0000085056.63483.d2.
Arnoni AS, Castro Neto J, Arnoni RT, et al. Infective endocarditis: 12 years of surgical treatment. Rev Bras Cir Cardiovasc. 2000;15(4):308-19. doi: 10.1590/S0102-76382000000400005.
Pazin GJ, Saul S, Thompson ME. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med. 1982;142(2):263-8. PMID: 7059254.
Podglajen I, Bellery F, Poyart C, et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis. 2003;9(12):1543-7. PMID: 14720393; doi: 10.3201/eid0912.030229.
Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366(26):2466-73. PMID: 22738096; doi: 10.1056/NEJMoa1112843.
